ArticleFrontiers in neurology2025
A simple risk index predicts endovascular treatment outcomes in acute ischemic stroke: prognostic value of SPAN-100.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Mechanical thrombectomy (MT) is a proven intervention for patients with acute ischemic stroke (AIS) due to a large vessel occlusion (LVO). However, outcomes after MT remain variable, particularly in high-risk groups. The SPAN-100 index, a simple bedside tool combining age and baseline NIHSS scores, has been associated with poor outcomes in AIS patients treated with intravenous thrombolysis. This study evaluates the prognostic value of the SPAN-100 index and its weighted variant (wSPAN) in predicting outcomes following MT. Methods: We conducted a retrospective cohort study of patients with AIS who were treated with MT between 2015 and 2024 at two Belgian university hospitals. SPAN and wSPAN scores were calculated at admission, and patients were stratified by SPAN ≥100 vs. <100. The primary outcome was functional status at 90 days, as assessed using the modified Rankin Scale (mRS). Secondary outcomes included mortality (mRS = 6) and favorable outcomes (mRS ≤ 3). Discriminative ability was assessed using receiver operating characteristic (ROC) analysis (AUC, 95% CI), and model performance was evaluated using AIC and BIC. The positive predictive value (PPV) and negative predictive value (NPV) were calculated for SPAN ≥100, and outcome proportions were compared between SPAN-defined groups using Fisher's exact test. Results: A total of 530 patients were included, of whom 116 had SPAN scores of ≥100. These patients experienced significantly worse outcomes, with higher mortality (60.0% vs. 17.6%) and lower rates of mRS ≤ 3 (19.2% vs. 71.6%, both Conclusion: SPAN-100 and wSPAN are pragmatic and reliable prognostic tools for AIS patients undergoing MT. While a SPAN score ≥100 identifies a high-risk group with poorer overall outcomes, it should not be used as an exclusion criterion. Many patients with a SPAN score ≥100 achieved functional recovery, supporting MT as a justified intervention even for older, more severely affected individuals. These findings highlight the importance of combining risk stratification with clinical judgment rather than relying on rigid thresholds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.